Posted in | News | Nanoelectronics

ARM, IBM to Develop Design Platforms Down to 14 nm Node for Advanced Consumer Electronics

ARM® [(LSE: ARM); (Nasdaq: ARMH)] and IBM (NYSE: IBM) today announced an agreement between the two companies to extend their collaboration on advanced semiconductor technologies to enable the rapid development of next generation mobile products optimized for performance and power efficiency.

The resulting technology will provide a suite of optimized physical and processor IP by ARM tuned to IBM’s advanced manufacturing process down to 14nm; providing streamlined development and earlier introduction of advanced consumer electronics into the marketplace.

As the consumers’ requirements increase for high-end features on mobile devices including; extended battery life, uninterrupted internet access, high end multimedia and secure transactions, the chip design becomes increasingly more challenging. Designers must consider nanometer -scale effects in terms of lithography, variability, and so on while simultaneously meeting performance, power and area (PPA) targets across hundreds of millions of transistors. This increased complexity potentially results in additional in-house design time.

Through this agreement ARM and IBM will collaboratively develop design platforms aligning the manufacturing process, microprocessor and physical IP design teams. This collaboration will minimize the risk and barriers to migrating to smaller geometries while enabling optimized density, performance, power and yield in advanced SoC designs; accelerating the introduction of advanced electronics into the marketplace.

“The ARM Cortex processor family has become the leadership platform for the majority of smart phones and many other emerging mobile devices,” said Michael Cadigan, general manager, IBM Microelectronics. “We plan to continue working closely with ARM and our foundry customers to speed the momentum of ARM technology by delivering highly advanced, low-power semiconductor technology for a variety of new communications and computing devices.”

“IBM has a proven track record of delivering the core research and development that is relied upon by major semiconductor vendors worldwide for their advanced semiconductor devices. Their leadership of the ISDA alliance, which features a diverse set of top-tier companies as members, is growing in importance as consolidation trends in the semiconductor manufacturing industry continue,” said Simon Segars, EVP and general manager, ARM physical IP division. “This agreement will ensure we are able to deliver highly tuned ARM Artisan Physical IP solutions on advanced ISDA process technologies to meet the early time-to-market our customers demand.”

Past collaboration with IBM and ARM on advanced geometries has been underway since 2008, resulting in the implementation of extensive process and physical IP refinements to improve SoC density, routability, manufacturability, power consumption, and performance. Moreover, through the previous collaboration on the 32nm and 28nm nodes, ARM has already delivered 11 test chips that provide concrete research structures and early silicon validation. In addition, ARM has developed specific optimizations targeting ARM processor cores including most recently a complete ARM Cortex-A9 processor core implemented on 32nm High-K Metal Gate technology.

Today’s agreement reinforces the aligned co-development of semiconductor process, foundation Physical IP building blocks, and microprocessor core optimization necessary to achieve market-leading system-on-chip (SoC) solutions. Furthermore, it extends access for ARM to continue this systematic test chip roadmap and assure early time-to-market readiness of the necessary platform of physical and processor IP solutions for nodes ranging from 20nm through 14nm.

Source: http://www.arm.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.